Skip to main navigation Skip to search Skip to main content

Dykellic acid inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting nuclear factor κB transcriptional activity

  • Ju Hyung Woo
  • , Jong Wook Park
  • , Sung Hee Lee
  • , Young Ho Kim
  • , In Kyu Lee
  • , Edward Gabrielson
  • , Sang Han Lee
  • , Ho Jae Lee
  • , Yung Hee Kho
  • , Taeg Kyu Kwon
  • Keimyung University
  • Korea Research Institute of Bioscience and Biotechnology
  • Johns Hopkins University

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Abstract

Proteolytic degradation of the extracellular matrix and tumor metastasis correlate with expression of endopeptidases known as matrix metalloproteinases (MMPs). Expression of MMPs is regulated by cytokines and signal transduction pathways, including those activated by phorbol myristate acetate. We found that dykellic acid, a fungal metabolite, significantly inhibits the phorbol myristate acetate-induced increase in MMP-9 expression and activity. These effects of dykellic acid are time- and dose-dependent, and correlate with decreased MMP-9 promoter activity and mRNA expression. Whereas this compound does not affect DNA binding activity of nuclear factor κB (NFκB), dykellic acid does inhibit transactivation of NFκB. These data demonstrate a role for NFκB in the regulation of MMP-9 expression and the ability of dykellic acid to suppress this action of NFκB.

Original languageEnglish
Pages (from-to)3430-3434
Number of pages5
JournalCancer Research
Volume63
Issue number12
StatePublished - 15 Jun 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Dykellic acid inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting nuclear factor κB transcriptional activity'. Together they form a unique fingerprint.

Cite this